Avience Biomedicals Reports Strong H1 FY27 Financial Results
Avience Biomedicals Ltd 路 Outcome 路 11 Nov 2026, 2:51 am
Avience Biomedicals Reports Strong H1 FY27 Financial Results Avience Biomedicals reported consolidated revenue from operations of Rs 3,112.86 lakhs for the half-year ended 30th Sep'26, up 16.07% YoY from Rs 2,681.93 lakhs in the half-year ended 30th Sep'25. Net profit rose 21.99% YoY to Rs 553.62 lakhs compared to Rs 453.78 lakhs, while basic and diluted EPS stood at Rs 10.10 against Rs 11.26. On a standalone basis, revenue reached Rs 2,368.69 lakhs with a net profit of Rs 466.64 lakhs. The company also utilised Rs 2,523.90 lakhs of its Rs 3,023.90 lakh IPO proceeds.
Original exchange filing (PDF)
More announcements from Avience Biomedicals Ltd
- Avience Biomedicals Limited has informed the Exchange about Link of Recording 路 18 Nov 2026
- Avience Biomedicals Limited has informed the Exchange about Investor Presentation 路 14 Nov 2026
- Avience Biomedicals Limited has informed the Exchange about Schedule of meet 路 12 Nov 2026
- Avience Biomedicals Limited has informed the Exchange about Board Meeting to be held on 10-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 10 Nov 2026
- To consider and approve the Standalone & Consolidated financial results for the period ended September 30, 2026 路 10 Nov 2026
- Avience Biomedicals Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q 30 September, 2026 FY 2026-27 路 29 Oct 2026
- Avience Biomedicals Limited has informed the Exchange about Outcome of Investor Conference 路 02 Oct 2026
- Avience Biomedicals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results. 路 01 Oct 2026
